Article Details
Retrieved on: 2019-10-08 07:48:45
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div><b>Man Group plc</b> boosted its position in Nektar Therapeutics (NASDAQ:NKTR) by 583.8% during the second quarter, according to the company in its ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here